ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 84 filers reported holding ANTARES PHARMA INC in Q1 2017. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $65,000 | +10.2% | 21,611 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $59,000 | +9.3% | 21,611 | +33.8% | 0.01% | +20.0% |
| Q3 2018 | $54,000 | +170.0% | 16,151 | +122.5% | 0.01% | +150.0% |
| Q2 2018 | $20,000 | +25.0% | 7,258 | 0.0% | 0.00% | +33.3% |
| Q1 2018 | $16,000 | +14.3% | 7,258 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $14,000 | -41.7% | 7,258 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $24,000 | +100.0% | 7,258 | +93.5% | 0.01% | +100.0% |
| Q2 2017 | $12,000 | +9.1% | 3,750 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $11,000 | +22.2% | 3,750 | 0.0% | 0.00% | +50.0% |
| Q4 2016 | $9,000 | +50.0% | 3,750 | 0.0% | 0.00% | +100.0% |
| Q3 2016 | $6,000 | +50.0% | 3,750 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $4,000 | +33.3% | 3,750 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $3,000 | – | 3,750 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,130,192 | $12,834,000 | 5.32% |
| Velan Capital Investment Management LP | 1,346,971 | $5,523,000 | 5.12% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,799,953 | $11,480,000 | 4.03% |
| Sargent Investment Group, LLC | 3,663,275 | $15,019,000 | 3.78% |
| PERKINS CAPITAL MANAGEMENT INC | 481,483 | $1,974,000 | 1.62% |
| Rubric Capital Management LP | 10,900,000 | $44,690,000 | 1.62% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,720,000 | $7,052,000 | 1.39% |
| Long Focus Capital Management, LLC | 540,000 | $2,214,000 | 0.28% |
| OBERWEIS ASSET MANAGEMENT INC/ | 344,200 | $1,411,000 | 0.28% |
| FIRETHORN WEALTH PARTNERS, LLC | 84,069 | $345,000 | 0.26% |